QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NASDAQ:NVIV

InVivo Therapeutics (NVIV) News Today

$1.31
-0.01 (-0.76%)
(As of 05/31/2023 ET)
Compare
Today's Range
$1.28
$1.33
50-Day Range
$0.90
$1.47
52-Week Range
$0.81
$13.77
Volume
20,810 shs
Average Volume
75,755 shs
Market Capitalization
$4.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get InVivo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter.



NVIV Media Mentions By Week

NVIV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVIV
News Sentiment

0.96

0.79

Average
Medical
News Sentiment

NVIV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVIV Articles
This Week

3

0

NVIV Articles
Average Week

SourceHeadline
MarketBeat logoInVivo Therapeutics (NASDAQ:NVIV) Now Covered by StockNews.com
americanbankingnews.com - May 26 at 3:48 AM
MarketBeat logoInVivo Therapeutics (NASDAQ:NVIV) Coverage Initiated at StockNews.com
americanbankingnews.com - May 17 at 5:20 AM
MarketBeat logoInVivo Therapeutics (NASDAQ:NVIV) Earns Sell Rating from Analysts at StockNews.com
americanbankingnews.com - May 2 at 2:44 AM
benzinga.com logoRing Therapeutics Strengthens Executive Team with Appointment of Christopher McNulty as Chief Financial Officer, Head of Corporate Strategy
benzinga.com - May 1 at 12:30 PM
MarketBeat logoInVivo Therapeutics (NASDAQ:NVIV) Coverage Initiated by Analysts at StockNews.com
americanbankingnews.com - April 15 at 7:28 AM
finance.yahoo.com logoWhy InVivo Therapeutics Shares Are Plunging Today
finance.yahoo.com - March 17 at 1:53 AM
msn.com logoInVivo seeks longer-term control in Casino-Teract retail tie-up
msn.com - March 10 at 6:45 PM
msn.com logoWhy Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
msn.com - March 10 at 6:45 PM
msn.com logoU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%
msn.com - March 10 at 3:10 AM
msn.com logoWhy JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
msn.com - March 9 at 5:08 PM
markets.businessinsider.com logoInVivo : INSPIRE 2.0 Study In Acute Spinal Cord Injury Fails To Meet Primary Endpoint
markets.businessinsider.com - March 9 at 5:08 PM
msn.com logoInVivo to evaluate strategic options as trial for spinal injury device fails
msn.com - March 9 at 5:08 PM
marketwatch.com logoInVivo Therapeutics Shares Hit 52-Week Low After Study Misses Primary Endpoint
marketwatch.com - March 9 at 5:08 PM
marketwatch.com logoInVivo Therapeutics Study for Neuro-Spinal Scaffold Misses Primary Endpoint
marketwatch.com - March 9 at 9:54 AM
finance.yahoo.com logoInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
finance.yahoo.com - March 9 at 9:54 AM
marketbeat.com logo
marketbeat.com - March 9 at 8:51 AM
benzinga.com logoInVivo Therapeutics Hldg Stock (NASDAQ:NVIV), Quotes and News Summary
benzinga.com - January 11 at 8:35 PM
finance.yahoo.com logoInVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - October 11 at 6:58 PM
marketwatch.com logoInVivo Therapeutics Shares Continue Friday's Fall, Hit All-Time Intraday Low
marketwatch.com - October 10 at 1:53 PM
seekingalpha.com logoInVivo Therapeutics dips 24% on $9M direct and private placement offerings
seekingalpha.com - October 7 at 1:56 PM
marketwatch.com logoInVivo Therapeutics Stock Drops on $9 Million Offering
marketwatch.com - October 7 at 1:56 PM
investorplace.com logoWhy Is InVivo Therapeutics (NVIV) Stock Down 34% Today?
investorplace.com - October 7 at 11:00 AM
finance.yahoo.com logoInVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - October 7 at 8:55 AM
marketbeat.com logo
marketbeat.com - October 6 at 3:47 PM
finance.yahoo.com logoInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 9 at 8:12 AM
uk.finance.yahoo.com logoInVivo Therapeutics Holdings Corp. (NVIV)
uk.finance.yahoo.com - August 28 at 8:41 PM
marketbeat.com logo
marketbeat.com - August 5 at 9:49 AM
marketbeat.com logo
marketbeat.com - August 4 at 10:47 AM
marketbeat.com logo
marketbeat.com - August 4 at 10:18 AM
marketbeat.com logo
marketbeat.com - August 4 at 10:07 AM
marketbeat.com logo
marketbeat.com - August 4 at 9:57 AM
marketbeat.com logo
marketbeat.com - August 4 at 9:44 AM
finance.yahoo.com logoInVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel
finance.yahoo.com - July 13 at 9:32 AM
finance.yahoo.com logoInVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery
finance.yahoo.com - June 8 at 9:06 AM
finance.yahoo.com logoInVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study
finance.yahoo.com - June 2 at 11:49 AM
finance.yahoo.com logoWhy Are InVivo Therapeutics Shares Trading Lower During Premarket Monday?
finance.yahoo.com - April 18 at 12:59 PM
nasdaq.com logoWhy InVivo Therapeutics Stock Falling?
nasdaq.com - April 15 at 8:14 AM
marketwatch.com logoInVivo Therapeutics Announces 1-for-25 Reverse Stock Split
marketwatch.com - April 14 at 10:13 PM
finance.yahoo.com logoInVivo Therapeutics stock sinks after 1-for-25 reverse stock split announced
finance.yahoo.com - April 14 at 10:13 PM
seekingalpha.com logoInVivo Therapeutics slumps 7% on 1-for-25 reverse stock split
seekingalpha.com - April 14 at 5:12 PM
finanznachrichten.de logoSidekick Health: DTx leader Sidekick announces key C-level hires in move to accelerate U.S. market growth
finanznachrichten.de - February 8 at 10:34 AM
finance.yahoo.com logoDTx leader Sidekick announces key C-level hires in move to accelerate U.S. market growth
finance.yahoo.com - February 8 at 10:34 AM
fool.com logoInVivo Therapeutics Holdings(NVIV)
fool.com - January 30 at 6:01 PM
finance.yahoo.com logoInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference
finance.yahoo.com - January 6 at 8:30 AM
nasdaq.com logoInVivo Therapeutics Holdings Corp Shares Fall 1.4% Below Previous 52-Week Low - Market Mover
nasdaq.com - December 29 at 1:16 AM
nasdaq.com logoInVivo Therapeutics Holdings Corp Shares Close the Day 11.0% Lower - Daily Wrap
nasdaq.com - December 29 at 1:16 AM
finance.yahoo.com logoInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference
finance.yahoo.com - September 9 at 4:17 PM
finance.yahoo.com logoInVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study
finance.yahoo.com - September 8 at 9:14 AM
morningstar.com logoInVivo Therapeutics Holdings Corp 04IC
morningstar.com - August 20 at 11:14 PM
nasdaq.com logoInVivo Therapeutics Holdings Corp Common Stock (NVIV)
nasdaq.com - August 7 at 10:38 PM
Get InVivo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NVIV) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -